ProShare Advisors LLC Makes New $2.34 Million Investment in Astera Labs, Inc. $ALAB

ProShare Advisors LLC acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, HoldingsChannel reports. The fund acquired 11,949 shares of the company’s stock, valued at approximately $2,340,000.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. State Street Corp grew its position in shares of Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after buying an additional 604,363 shares during the last quarter. 1832 Asset Management L.P. increased its stake in shares of Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Astera Labs by 46.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after acquiring an additional 479,360 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Astera Labs by 36.2% in the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after acquiring an additional 330,841 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Morgan Stanley reissued an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research report on Wednesday, December 3rd. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. JPMorgan Chase & Co. increased their price target on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Finally, Northland Securities upped their target price on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Fourteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer directly owned 1,599,750 shares in the company, valued at approximately $231,467,827.50. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. This trade represents a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 576,936 shares of company stock valued at $87,409,540. Company insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $129.32 on Friday. The firm has a market capitalization of $21.84 billion, a P/E ratio of 106.00, a PEG ratio of 2.80 and a beta of 1.50. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company’s 50-day simple moving average is $164.09 and its 200 day simple moving average is $174.51.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period last year, the business earned $0.37 earnings per share. The business’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.